Bazedoxifene
CAS No. 198481-32-2
Bazedoxifene ( TSE-424 )
产品货号. M29641 CAS No. 198481-32-2
Bazedoxifene (TSE-424) is an oral, BBB-penetrant nonsteroidal selective estrogen receptor modulator (SERM), with IC50s of 23 nM and 99 nM for ERα and ERβ, respectively.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥787 | 有现货 |
|
| 10MG | ¥1169 | 有现货 |
|
| 25MG | ¥2306 | 有现货 |
|
| 50MG | ¥3469 | 有现货 |
|
| 100MG | ¥4788 | 有现货 |
|
| 200MG | ¥6552 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥847 | 有现货 |
|
生物学信息
-
产品名称Bazedoxifene
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Bazedoxifene (TSE-424) is an oral, BBB-penetrant nonsteroidal selective estrogen receptor modulator (SERM), with IC50s of 23 nM and 99 nM for ERα and ERβ, respectively.
-
产品描述Bazedoxifene (TSE-424) is an oral, BBB-penetrant nonsteroidal selective estrogen receptor modulator (SERM), with IC50s of 23 nM and 99 nM for ERα and ERβ, respectively. Bazedoxifene can be used for the research of osteoporosis. Bazedoxifene also acts as an inhibitor of IL-6/GP130 protein-protein interactions and can be used for the research of pancreatic cancer.Bazedoxifene is a small molecular GP130 inhibitor, which binds to GP130 D1 domain.Bazedoxifene inhibits STAT3 phosphorylation induced by Il-6 and IL-11 in GP130/STAT3 pathway signaling.Bazedoxifene (10 μM-20 μM; 2 hours) inhibits STAT3 Phosphorylation Induced by cytokines in human pancreatic cancer cells.Bazedoxifene (5-20 μM; overnight) induces apoptosis in human pancreatic cancer cells.Bazedoxifene inhibits STAT3 nuclear translocation induced by IL-6.Bazedoxifene blocks the cells migration in pancreatic cancer cells by inhibition of GP130.
-
体外实验Bazedoxifene is a small molecular GP130 inhibitor, which binds to GP130 D1 domain.Bazedoxifene inhibits STAT3 phosphorylation induced by Il-6 and IL-11 in GP130/STAT3 pathway signaling.Bazedoxifene (10 μM-20 μM; 2 hours) inhibits STAT3 Phosphorylation Induced by cytokines in human pancreatic cancer cells.Bazedoxifene (5-20 μM; overnight) induces apoptosis in human pancreatic cancer cells.Bazedoxifene inhibits STAT3 nuclear translocation induced by IL-6.Bazedoxifene blocks the cells migration in pancreatic cancer cells by inhibition of GP130. Western Blot Analysis Cell Line:AsPC-1 cells Concentration:10 μM, 20 μM Incubation Time:2 hours Result:Inhibited IL-6, IL-11 or OSM (50 ng/mL) induced STAT3 phosphorylation. Apoptosis Analysis Cell Line:Capan-1 cells, BxPC-3 cells, HPAF-II cells, HPAC cells Concentration:10 μM, 20 μM (Capan-1); 5 μM, 10 μM (BxPC-3); 10 μM, 20 μM (HPAF-II); 10 μM, 15 μM (HPAC)Incubation Time:Overnight Result:Induced apoptosis.
-
体内实验Bazedoxifene (5 mg/kg; i.g.; daily, for 18 days) inhibits Capan-1 tumor growth in mouse model in vivo. Animal Model:6-week-old female athymic nude mice Dosage:5 mg/kg Administration:Oral gavage, daily, for 18 days Result:Suppressed pancreatic cancer xenograft tumor growth and induced apoptosis in tumor cells.
-
同义词TSE-424
-
通路Endocrinology/Hormones
-
靶点Estrogen Receptor/ERR
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number198481-32-2
-
分子量470.6
-
分子式C30H34N2O3
-
纯度>98% (HPLC)
-
溶解度DMSO : 100 mg/mL (212.49 mM; Need ultrasonic)
-
SMILESCC1=C(C2=CC=C(O)C=C2)N(CC3=CC=C(OCCN4CCCCCC4)C=C3)C5=CC=C(O)C=C51
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Barry S Komm, et al. Bazedoxifene acetate: a selective estrogen receptor modulator with improved selectivity. Endocrinology. 2005 Sep;146(9):3999-4008.
2. Xiaojuan Wu, et al. Bazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy. Mol Cancer Ther. 2016 Nov; 15(11): 2609–2619.
产品手册
关联产品
-
Serba-2
Serba-2 是苯并吡喃选择性雌激素受体 β 的激动剂。
-
Isopsoralenoside
异补骨脂素具有类雌激素、促进成骨细胞增殖、抗肿瘤和抗菌作用。补骨脂素 (P)、异补骨脂素 (IP)、补骨脂素 (PO) 和异补骨脂素 (IPO) 是补骨脂中主要的香豆素类和香豆素相关苯并呋喃糖苷类化合物,据报道显示出雌激素样活性、成骨细胞增殖加速活性、抗肿瘤作用和抗菌活性。
-
PROTAC ERRα ligand 1
PROTAC ERRα配体1是雌激素相关受体的α(ERRα)拮抗剂(ERRα和ERRγ的IC50分别为0.04和2.8μM)。
021-51111890
购物车()
sales@molnova.cn

